SCM
ABMD

Stevens Capital Management’s Abiomed Inc ABMD Stock Holding History

Stevens Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,186
Closed -$1.57M – 501
2019
Q4 		$1.57M Sell
9,186
-662
-7% -$123K 0.15% 159
2019
Q3 		$1.75M Sell
9,848
-3,704
-27% -$801K 0.16% 163
2019
Q2 		$3.53M Sell
13,552
-7,006
-34% -$1.86M 0.16% 174
2019
Q1 		$5.87M Buy
20,558
+5,795
+39% +$1.93M 0.25% 128
2018
Q4 		$4.8M Buy
+14,763
New +$5.13M 0.25% 129
2018
Q3 		– Sell
-12,330
Closed -$5.04M – 1017
2018
Q2 		$5.04M Buy
+12,330
New +$4.47M 0.18% 140
2017
Q3 		– Sell
-8,281
Closed -$1.19M – 1127
2017
Q2 		$1.19M Buy
+8,281
New +$1.11M 0.04% 388
2017
Q1 		– Sell
-18,572
Closed -$2.09M – 1159
2016
Q4 		$2.09M Buy
+18,572
New +$2.15M 0.09% 304
2016
Q3 		– Sell
-11,848
Closed -$1.29M – 1203
2016
Q2 		$1.29M Buy
+11,848
New +$1.18M 0.05% 374
2013
Q4 		– Sell
-47,409
Closed -$904K – 1294
2013
Q3 		$904K Buy
47,409
+6,889
+17% +$157K 0.03% 507
2013
Q2 		$874K Buy
+40,520
New +$814K 0.03% 463

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Stevens Capital Management's ABMD Position: Q1 2020 in Review

Stevens Capital Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 9,186 shares — an estimated $1.57M sold.

Stevens Capital Management first reported a position in ABMD in Q2 2013 and held it in 11 quarters. The position peaked at $5.87M in Q1 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Stevens Capital Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 9,186 Abiomed Inc shares in Q1 2020, an estimated $1.57M.
  • Stevens Capital Management first reported a position in Abiomed Inc in Q2 2013 and held it in 11 quarters.
  • Stevens Capital Management's Abiomed Inc position peaked at $5.87M in Q1 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.